AABB Accreditation Standards for Cord Blood Banks
AABB accreditation confirms a bank has systems to catch errors, not whether its science is sound.
AABB accreditation is the main quality benchmark cord blood banks use to prove they meet defined standards across every stage of handling a family's stem cells, from the moment blood is drawn from the umbilical cord to the day a unit gets released for transplant. The organization behind it, the Association for the Advancement of Blood & Biotherapies, has had standards at the backbone of its mission since 1957 and folded cord blood banking into its scope more than two decades ago. Here is the part families tend to skip past: accreditation tells you the bank has a system built to catch its own mistakes. It does not tell you whether the bank is any good at the science of stem cell preservation itself, and confusing the two is where most cord blood shopping goes wrong.
AABB started in 1947 as the American Association of Blood Banks and changed its name in 2021 to reflect a mission that had outgrown transfusion medicine into cellular therapies broadly. It is an international nonprofit now, with standards that apply to accredited facilities in more than 50 countries. Nearly every blood bank operating in the United States carries AABB accreditation, which tells you how deeply the organization sits in the plumbing of transfusion and cellular therapy medicine. It is the default requirement that applies across the industry. It is the default, and a bank that lacks it has some explaining to do.
The governing document
Cord blood banks get accredited against a specific rulebook called the Standards for Cellular Therapy Services, shortened to the CT Standards. AABB folded cord blood requirements into this document in 2004, and it has been revised on a regular cycle since. The version in force now is the 12th edition, effective July 1, 2025, split into two halves: broad quality standards that apply across an organization, and technical standards specific to the work being done.
A 13th edition is already moving through the pipeline. AABB opened a public comment period on the draft, with feedback due April 14, a deadline that has already passed as of this writing. That roughly two-year revision rhythm shows AABB treats its rulebook as a living document, one that has to keep pace with a field where the science, the technology, and clinical practice around cellular therapy are all moving at once. A standard written in 2023 for a controlled-rate freezer, for instance, has to account for validation methods that did not exist when the prior edition went to print.
The Quality Systems Essentials framework that underpins every requirement
Every requirement in the CT Standards sits on top of a quality management structure AABB calls Quality Systems Essentials, or QSEs. The framework goes back to 1997, when AABB rolled it out through Association Bulletin #97-04, and that bulletin marked a genuine shift in philosophy. Before it, blood banking quality control mostly meant catching errors after they happened. After it, the goal became stopping errors before they occurred. A set of core elements made up the original QSE framework, and every accredited facility has to build its operations around them. None of them are optional add-ons a bank can skip if it is short-staffed.
AABB updated the framework again in 2023, calling it the next stage in how quality gets defined across blood banking and cellular therapy work. The QSEs touch organizational structure, how resources and equipment get managed, how materials are tracked, how documentation gets handled, and how a facility checks its own program on an ongoing basis. Confirming a bank froze cells correctly is one question. Confirming the bank has a system that would have caught a freezing mistake before it ever reached a patient is another, and that second question is the one AABB actually asks. Accreditation matters because it confirms the bank has a system that catches errors like a freezing mistake before they reach a patient, unlike a single glowing testimonial on a bank's website.
Standards required at each stage of cord blood banking operations
The CT Standards follow a cord blood unit through its entire life: donor screening, collection, processing, testing, freezing, storage, release, clinical administration, and monitoring what happens to the patient afterward. That end-to-end scope is what separates a real accreditation framework from a checklist bolted onto a single step. Donor screening deserves more attention than families usually give it.
Donor screening starts with the mother, and it is the single most important gate in the chain. No amount of careful freezing downstream fixes a contaminated starting material, so facilities need written policies spelling out eligibility criteria. As part of the accreditation application, a bank has to complete an Infectious Disease Testing Questionnaire built specifically for cord blood facilities, and maternal infectious disease testing is required, full stop.
Collection gets treated as one continuous set of requirements covering consent, screening, and the physical collection itself, all governed by written procedures a facility has to follow step by step. There is no improvising at the bedside, and the standards are not written to leave room for it.
Processing and testing is where the detail gets genuinely technical, and marketing language often blurs baseline requirements into things that sound impressive. Processing requirements address how a unit must be prepared before cryopreservation, including separation and depletion steps carried out under written procedures a facility must follow. A cryoprotectant, typically dimethyl sulfoxide (DMSO), gets added to protect the cells during freezing. The standards address cryopreservation method requirements, with the goal of ensuring cell viability is maintained through the freezing process. The standards place the burden of demonstrating product viability on the facility, whatever method it uses. Every unit also has to clear product qualification and testing requirements before release.
The accreditation process from application through on-site assessment
A facility cannot apply until it has operated in the activity it wants accredited for at least six months. That waiting period exists so AABB is assessing an actual track record, not a business plan.
The process runs in three phases. Phase one is the application: the facility joins AABB as an institutional member, then submits three activity-specific questionnaires covering ISBT 128 labeling, infectious disease testing, and cord blood. A Locations Table has to accompany the application, listing every physical site and what activity happens there. Payment is not bundled into the paperwork; AABB invoices separately, after submission.
Phase two moves the facility into self-assessment, done through AABB's online portal, APEX (Accreditation Portal). Inside APEX, a facility uploads documents, tracks progress, and communicates with AABB through the platform's built-in channels. Self-assessment means checking operations against every single standard in the CT Standards, and each one has to be backed by a written policy, process, or procedure, referred to internally as a PPP. AABB has to review and approve that self-assessment before anything moves forward. No approval, no site visit. That sequencing is deliberate. Nobody gets an in-person inspection until the paperwork holds up on its own.
Phase three is the on-site assessment, and this is where the paper trail gets tested against reality. AABB sends assessors to verify that the PPPs on record match what is actually happening on the floor. They pull sample records, watch procedures in progress, and flag anything that does not line up. Every facility where processing takes place gets visited, no exceptions. For banks running multiple collection and storage sites, AABB visits between 1 and 10 percent of those locations every two years, rotating through the network so every site eventually gets seen.
Maintaining accreditation and renewal requirements every two years
AABB accreditation expires after two years, and renewal is not a formality. The facility goes through the entire process again: a fresh self-assessment in APEX, followed by another on-site visit.
Assessors show up at renewal expecting proof that written PPPs are actually being followed, and the bar does not soften because a facility has already been accredited once before. The standards do not soften for facilities that have previously held accreditation. If the on-site team finds nonconformances during the renewal visit, the facility has to resolve them before accreditation continues. Nonconformances found during renewal have to be resolved before accreditation continues, keeping the integrity of the two-year framework intact.
How AABB accreditation relates to FDA registration, CLIA, and HRSA
AABB accreditation is voluntary, and that single word changes how the whole system should be read. The standards sit on top of federal and state law. They do not replace it. AABB describes its own standards as the minimum acceptable bar for facilities doing this work, and that is a strange position for a voluntary program to hold: not legally required anywhere, yet functioning as the de facto floor the entire industry has settled around. A bank that skips AABB accreditation is choosing not to clear the bar everyone else in the field has agreed to clear. It is just choosing not to clear the bar everyone else in the field has agreed to clear.
Federal law runs on its own separate track. Family cord blood banks, the kind parents pay to store their own child's cord blood, have to register with the FDA and are subject to federal oversight and inspection. Public banks, which collect donated cord blood for any matching patient, face additional federal requirements, including FDA biologics licensing. A given bank can hold AABB accreditation, FDA registration, and CLIA certification simultaneously, and these are three separate relationships with three separate bodies. Holding one never substitutes for the other two, no matter how the marketing on a bank's website might frame it. A bank that leads with "FDA registered" in its pitch is describing a legal obligation, not an achievement, and families should read it that way.
CLIA certification recently changed in a way that actually simplifies things. A federal health regulator granted AABB deeming authority for its Cellular Therapy program, effective April 25, 2024 through April 25, 2030. In practice, that means a facility already accredited by AABB in cellular therapy does not have to run a separate CLIA certification process from scratch. The AABB accreditation itself satisfies CLIA's requirements, at least for as long as that deeming authority stays in effect.
AABB is not the only voluntary accrediting body a cord blood bank might pursue. The other major one is FACT, the Foundation for the Accreditation of Cellular Therapy, and the two organizations approach the same basic goal from genuinely different angles. Families who see one but not the other on a bank's site should not assume the worst. There is a structural reason for it, and it comes down to timing more than quality.
AABB casts a wide net across cellular therapies generally, blending international quality management principles with technical detail, and its accreditation is recognized by CMS. Its standards revise roughly every two years, which keeps the document current but also means a facility is never fully done adapting. FACT focuses specifically on cellular therapy and cord blood banking, with standards oriented around the operational and clinical dimensions of that work. The two bodies approach the same goal from different angles, and a bank that carries only one accreditation is not necessarily hiding anything about the other.
The two bodies also differ in a way that shapes when a bank can even apply, and most families miss this detail. FACT's entry threshold is tied to the volume of units a facility has banked rather than to time of operation. AABB's threshold has nothing to do with volume: six months of operation in the activity being accredited, regardless of how many units that operation has produced. A newer bank with a modest inventory can clear AABB's bar long before it could ever meet FACT's storage requirement. So a bank carrying AABB accreditation years before FACT accreditation appears on the same paperwork is not a red flag. One organization measures readiness in months of operation, the other measures it in units banked, so a young facility will always hit the first number before it hits the second.
